Navamya Acharya

Investing.com -- Novartis (SIX:NOVN) on Thursday posted a 24% rise in second-quarter net income to $4 billion, as sales of key therapies including Kisqali and Entresto drove...

Investing.com -- Bernstein has initiated coverage on Clariane (F:KORI) with an “outperform” rating and a price target of €6.80 per share, implying a 33% upside from its €5.13...

Investing.com -- Goldman Sachs has initiated coverage of UCB (EBR:UCB) with a “buy” rating and a 12-month price target of €250, representing a 46.5% upside from the current share...

Investing.com -- Hiscox (LON:HSX) has been upgraded to "overweight" by Morgan Stanley (NYSE:MS), which raised its price target from 1,280p to 1,460p, in a note dated...

Investing.com -- UBS has upgraded Aena SME SA (BME:AENA) to "buy" from "neutral" and raised its 12-month price target to €26.80 from €22, citing improved expectations for...

Investing.com -- Bernstein Research initiated coverage on Brunello Cucinelli and Salvatore Ferragamo, offering contrasting outlooks reflective of their brand positioning and...

Investing.com -- Deutsche Bank (ETR:DBKGn) downgraded Brenntag AG (ETR:BNRGn) to “hold” from “buy,” on Wednesday and sharply lowered its price target to €52 from €75, a 30.7%...

Investing.com -- Shares of Norwegian hydrogen company NEL ASA (OL:NEL) fell more than 4% on Wednesday following the release of its first-half 2025 earnings, which showed sharp...

Investing.com -- Dalata Hotel Group (IR:DHG) has been downgraded to “neutral” from “buy” by UBS following a recommended €6.45 per share cash offer by Pandox Ireland, a company...